4G/5G Promoter PAI-1 Gene Polymorphism Is Associated with Plasmatic PAI-1 Activity in Italians: A Model of Gene-Environment Interaction
- 1 January 1998
- journal article
- letter
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 79 (02) , 354-358
- https://doi.org/10.1055/s-0037-1614991
Abstract
The PAI-1 gene promoter 4G/5G polymorphism was found to be associated with plasma PAI-1 activity in Northern and Central Europe populations, but no data are available on the association between this polymorphism and PAI-1 levels in Southern Europe countries (such as Italy) where the incidence of ischemic disorders is lower. This study shows that among populations with different incidence of atherothrombotic disorders the 4G/5G PAI-1 gene promoter polymorphism has the same importance in the regulation of plasma PAI-1 activity. Moreover, we have analysed some gene-environmental interactions: the correlation between PAI-1 and cholesterol in non dyslipidemic subjects and the correlation between PAI-1 activity and tryglicerides in dyslipidemic subjects differed according to the 4G/5G genotype class. Thus, our findings suggest that, among subjects with or without metabolic disorders such as dyslipidemia, completely different gene-environment interactions may occur. * On leave of absence from the Institute of Cardiology, Catholic University, Rome, Italy.Keywords
This publication has 11 references indexed in Scilit:
- Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.Proceedings of the National Academy of Sciences, 1995
- Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina PectorisNew England Journal of Medicine, 1995
- Fibrinolysis and atherosclerosis: An updateFibrinolysis, 1994
- Prospective study of endogenous tissue plasminogen activator and risk of strokeThe Lancet, 1994
- Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Role of family history in patients with myocardial infarction. An Italian case-control study. GISSI-EFRIM Investigators.Circulation, 1992
- Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Genetic variation at the plasminogen activator inhibitor-1 (PAI-1) locusFibrinolysis, 1990
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985